Dr. Carl June Discusses the Next Generation of Gene Therapy

Jun 04, 2018

ACGT Fellow and Scientific Advisory Council Member, Dr. Carl June, talks about making the next generation of CAR T therapies more potent and safer for patients. These include combination therapies for solid tumors and treatments with less toxic side effects. “Cure is a big word,” he remarks.

Read More

ACGT Fellow, Dr. Samuel Katz Speaks About Cell & Gene Cancer Research Funding

Jun 21, 2017

Alliance for Cancer Gene Therapy fellow, Dr. Samuel Katz at Yale Medical Center, speaks about cell and gene therapies for cancer treatment.

There has been great progress in harnessing a patient’s own immune cells to attack blood cancers. Most protocols use DNA to alter the cells,

Read More

We Are Not Going to Cure Cancer without T Cells – Dr. Michael Lotze

Oct 05, 2016

Dr. Michael Lotze, Member of Alliance for Cancer Gene Therapy’s Scientific Advisory Council speaks about progress in the fight against cancer he has witnessed during his esteemed career. “I believe that we are not going to cure cancer without T cells,” stated Dr. Lotze.

Read More

Personalized Therapies are the Future of Cancer Care with Dr. Stephen Eck

Oct 05, 2016

Dr. Stephen Eck, Member of Alliance for Cancer Gene Therapy’s Scientific Advisory Council, talks about the importance of personalized therapies for cancer. “Historically, we’ve tried to develop therapies that are good for the average patient. When none of us are all that average,” Dr.

Read More

Adoptive T Cell Therapy to Attack Leukemia – with ACGT Scientist Dr. Yvonne Chen

Sep 16, 2016

2015 – 2016 ACGT Young Investigator, Yvonne Chen, MS, PhD, speaks about using engineered T cells to cure leukemia in this video from May 2016.

Great progress has been made in harnessing a patient’s own immune cells to attack various cancers. Also known as Adoptive T Cell therapy,

Read More

Laurence Cooper, MD, PhD, ACGT Fellow, Speaks on the Power of Immunotherapy to Fight Cancer

Jan 11, 2016

Dr. Laurence Cooper, Alliance for Cancer Gene Fellow speaks about the breakthroughs in Immunotherapy to destroy cancer and translate ideas from the bench to the bedside. Dr. Cooper is Chief Executive Officer of Ziopharm Oncology. Dr. Cooper is tenured professor, Pediatrics and Immunology; Section Chief,

Read More

Michael Lotze, MD, Member, Speaks about Research using Cell and Gene Therapy for Cancer Treatment

Dec 15, 2015

Dr. Michael Lotze, Member of the Alliance for Cancer Gene Therapy Scientific Advisory Council speaks about progress in the research using cell and gene therapy for cancer treatment. Dr. Lotze is Professor of Surgery and Bioengineering; Vice Chair Research, Department of Surgery; Director, Strategic Partnerships,

Read More

John Bell, PhD, ACGT Scientific Advisory Council Member and Research Fellow and the Power of Combination Therapies

Dec 15, 2015

Dr. John Bell, Alliance for Cancer Gene Fellow and Scientific Advisory Council member speaks about the complex nature of cancer and his understanding that a combination therapy may provide the cancer answer. Dr. Bell is Senior Research Scientist and Professor of Medicine, Ottawa Hospital Research Institute,

Read More